CD19 CAR circRNA

Biorbyt

CD19 CAR circRNA

10

Research Use Only

98.00%

CD19 CAR circRNA, expressing CD19 car protein, is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19). This compound involves a chimeric antigen receptor, CD19, a CD molecule present on B cells (i.e., leukocyte differentiation antigen), crucial for B cell proliferation, differentiation, activation, and antibody production, and facilitates BCR signal transduction.

-20°C

12352200